VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Saturday, January 10, 2026
Stock Comparison
AstraZeneca PLC vs Teqnion AB (publ)
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
AstraZeneca PLC
AZN · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.
View AZN analysisTeqnion AB (publ)
TEQ · Nasdaq First North Growth Market Sweden
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Teqnion AB (publ)'s moat claims, evidence, and risks.
View TEQ analysisComparison highlights
- Moat score gap: AstraZeneca PLC leads (71 / 100 vs 47 / 100 for Teqnion AB (publ)).
- Segment focus: AstraZeneca PLC has 6 segments (41% in Oncology); Teqnion AB (publ) has 4 segments.
- Primary market structure: Oligopoly vs Competitive. Pricing power: Strong vs n/a.
- Moat breadth: AstraZeneca PLC has 4 moat types across 3 domains; Teqnion AB (publ) has 8 across 2.
Primary market context
AstraZeneca PLC
Oncology
Innovator oncology therapeutics (branded prescription medicines)
Global
Hospitals, oncology clinics, payers
Innovator biopharmaceutical company
41%
Teqnion AB (publ)
Acquisition & Portfolio Platform (Active, long-term ownership)
Acquisition and long-term ownership of profitable niche industrial SMEs
Nordics, UK, Ireland
Business owners / sellers; subsidiary management teams
Acquirer / holding company / active owner
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
AstraZeneca PLC strengths
Teqnion AB (publ) strengths
Segment mix
AstraZeneca PLC segments
Full profile >Oncology
Oligopoly
Cardiovascular, Renal and Metabolism (CVRM)
Competitive
Respiratory & Immunology (R&I)
Oligopoly
Vaccines & Immune Therapies (V&I)
Oligopoly
Rare Disease
Oligopoly
Other Medicines
Competitive
Teqnion AB (publ) segments
Full profile >Acquisition & Portfolio Platform (Active, long-term ownership)
Competitive
Agency & Distribution Businesses
Competitive
Niche Product & Service Companies
Competitive
Manufacturing (Own-brand and Contract/OEM)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.